Recherche - Archive ouverte HAL

83 résultats

	Pour les 83 documents Envoyer sur ORCID RSS ATOM Exporter BibTeX XML-TEI CSV RTF EndNote PDF HTML Export avancé	Page : Page précédente 1 2 3 Page suivante	triés par Pertinence Auteur A→Z Auteur Z→A Titre A→Z Titre Z→A Date de publication croissante Date de publication décroissante Date de dépôt croissante Date de dépôt décroissante

		The HER3/ERBB3 receptor: the dark side of the ERBB planet Christel Larbouret , Nadège Gaborit , Marie-Alix Poul , André Pèlegrin , Thierry Chardès Médecine/Sciences, 2015, 31 (5), pp.465-468. ⟨10.1051/medsci/20153105002⟩ Article dans une revue hal-02285139v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery Marian Gutowski , Bérénice Framery , Martin Boonstra , Véronique Garambois , François Quenet , et al. Surgical Oncology, 2017, 26 (2), pp.153-162. ⟨10.1016/j.suronc.2017.03.002⟩ Article dans une revue hal-02371819v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen. Ghislaine Behar , Patrick Chames , Isabelle Teulon , Amélie Cornillon , Faisal Alshoukr , et al. FEBS Journal, 2009, 276 (14), pp.3881-93. ⟨10.1111/j.1742-4658.2009.07101.x⟩ Article dans une revue hal-00420547v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer. David Azria , Frédéric Bibeau , Nicolas Barbier , Abderrahim Zouhair , Claire Lemanski , et al. BMC Cancer, 2005, 5, pp.62. ⟨10.1186/1471-2407-5-62⟩ Article dans une revue inserm-00090458v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation Christophe Le Clorennec , Yassamine Lazrek , Olivier Dubreuil , Christel Larbouret , Marie-Alix Poul , et al. Oncotarget, 2016, 7 (24), pp.37013-37029. ⟨10.18632/oncotarget.9455⟩ Article dans une revue hal-02297403v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Symplekin promotes tumorigenicity by up-regulating claudin-2 expression Michael Buchert , Marina Papin , Caroline Bonnans , Charbel Darido , Warren Raye , et al. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107 (6), pp.2628-2633. ⟨10.1073/pnas.0903747107⟩ Article dans une revue hal-03108425v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Examination of HER3 targeting in cancer using monoclonal antibodies Nadège Gaborit , Ali Abdul-Hai , Maicol Mancini , Moshit Lindzen , Sara Lavi , et al. Proceedings of the National Academy of Sciences of the United States of America, 2015, 112 (3), pp.839-844. ⟨10.1073/pnas.1423645112⟩ Article dans une revue hal-02276327v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity Jérôme Lacombe , Muriel Brengues , Alain Mangé , Céline Bourgier , Sophie Gourgou , et al. Radiation Oncology, 2019, 14 (1), pp.142. ⟨10.1186/s13014-019-1351-8⟩ Article dans une revue hal-02371868v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6 th antibody industrial symposium, June 25-26, 2018, Montpellier, France Pierre Martineau , Herve Watier , André Pèlegrin , Andrei Turtoi mAbs, 2019, 11 (5), pp.812-825. ⟨10.1080/19420862.2019.1612691⟩ Article dans une revue hal-02448613v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Apoptosis and p53 are not involved in the anti-tumor efficacy of (125)I-labeled monoclonal antibodies targeting the cell membrane. Salomé Paillas , Laurent Boudou , Bérengère Piron , Nathalie Kersual , Manuel Bardiès , et al. Nuclear Medicine and Biology, 2013, epub ahead of print. ⟨10.1016/j.nucmedbio.2013.02.001⟩ Article dans une revue inserm-00815724v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis Nina Radosevic-Robin , Wilhem Leconet , Myriam Chentouf , Stanislas Du Manoir , Clément Chevalier , et al. Clinical Cancer Research, 2017, 23 (11), pp.2806 - 2816. ⟨10.1158/1078-0432.CCR-16-1316⟩ Article dans une revue hal-01676378v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures Christel Larbouret , Laurent Gros , André Pèlegrin , Thierry Chardès Cancers, 2021, 13 (18), pp.4620. ⟨10.3390/cancers13184620⟩ Article dans une revue hal-03360265v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent Charlotte Hoogstins , Leonora Boogerd , Babs Sibinga Mulder , J. Sven D. Mieog , Rutger Jan Swijnenburg , et al. Annals of Surgical Oncology, 2018, 25 (11), pp.3350-3357. ⟨10.1245/s10434-018-6655-7⟩ Article dans une revue hal-02289226v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Anti-HER2 vaccines: new prospects for breast cancer therapy. Maha Zohra Ladjemi , William Jacot , Thierry Chardès , André Pèlegrin , Isabelle Navarro-Teulon Cancer Immunology, Immunotherapy, 2010, 59 (9), pp.1295-312. ⟨10.1007/s00262-010-0869-2⟩ Article dans une revue inserm-00491487v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		[Anti-HER2 vaccines: The HER2 immunotargeting future?] Maha-Zohra Ladjemi , William Jacot , André Pèlegrin , Isabelle Navarro-Teulon Pathologie Biologie, 2009, epub ahead of print. ⟨10.1016/j.patbio.2009.04.002⟩ Article dans une revue inserm-00396298v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients Bérénice Framery , Marian Gutowski , Karen Dumas , Alexandre Evrard , Nathalie Muller , et al. Toxicology Reports, 2019, 6, pp.409--415. ⟨10.1016/j.toxrep.2019.04.011⟩ Article dans une revue hal-02931825v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial Eric Assenat , David Azria , Caroline Mollevi , Rosine Guimbaud , Nicole Tubiana-Mathieu , et al. Oncotarget, 2015, 6 (14), ⟨10.18632/oncotarget.3473⟩ Article dans une revue hal-02005981v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models Emilia Rabia , Véronique Garambois , Julie Hubert , Marine Bruciamacchie , Nelly Pirot , et al. mAbs, 2021, 13 (1), pp.1914883. ⟨10.1080/19420862.2021.1914883⟩ Article dans une revue hal-03360283v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodies. Nadège Gaborit , Christel Larbouret , Julie Vallaghe , Frédéric Peyrusson , Caroline Bascoul-Mollevi , et al. Journal of Biological Chemistry, 2011, 286 (13), pp.11337-45. ⟨10.1074/jbc.M111.223503⟩ Article dans une revue inserm-00576598v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts. Myriam Chentouf , Maxime Rigo , Soufiane Ghannam , Isabelle Navarro-Teulon , Sébastien Mongrand , et al. Immunology Letters, 2010, 133 (2), pp.62-9. ⟨10.1016/j.imlet.2010.07.003⟩ Article dans une revue inserm-00508402v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein. Claire Germain , Emmanuelle Campigna , Imed Salhi , Sébastien Morisseau , Isabelle Navarro-Teulon , et al. Protein Engineering, Design and Selection, 2008, 21 (11), pp.665-72. ⟨10.1093/protein/gzn047⟩ Article dans une revue inserm-00325786v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption. Christel Larbouret , Nadège Gaborit , Thierry Chardès , Mickaël Coelho , Emmanuelle Campigna , et al. Neoplasia, 2012, 14 (2), pp.121-30. ⟨10.1593/neo.111602⟩ Article dans une revue inserm-00682017v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer. Marc Ychou , David Azria , Cathy Menkarios , Patrick Faurous , François Quenet , et al. Clinical Cancer Research, 2008, 14 (11), pp.3487-93. ⟨10.1158/1078-0432.CCR-07-4698⟩ Article dans une revue inserm-00292535v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions Madeline Neiveyans , Rana Melhem , Christophe Arnoult , Thomas Bourquard , Marta Jarlier , et al. mAbs, 2019, 11 (3), pp.593-605. ⟨10.1080/19420862.2018.1564510⟩ Article dans une revue hal-02325764v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation. Yassamine Lazrek , Olivier Dubreuil , Véronique Garambois , Nadège Gaborit , Christel Larbouret , et al. Neoplasia, 2013, 15 (3), pp.335-47. ⟨10.1593/neo.121960⟩ Article dans une revue inserm-00815985v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells Laura Bourillon , Sylvain Demontoy , Alexis Lenglet , Alexandre Zampieri , Julien Fraisse , et al. International Journal of Radiation Oncology, Biology, Physics, 2020, 106 (5), pp.1039-1051. ⟨10.1016/j.ijrobp.2019.12.020⟩ Article dans une revue hal-03038992v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. David Azria , Mahmut Ozsahin , Andrew Kramar , Sheila Peters , David P Atencio , et al. Clinical Cancer Research, 2008, 14 (19), pp.6284-8. ⟨10.1158/1078-0432.CCR-08-0700⟩ Article dans une revue inserm-00337542v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells Christophe Le Clorennec , Yassamine Lazrek , Olivier Dubreuil , Carla Sampaio , Christel Larbouret , et al. Cell Communication and Signaling, 2019, 17 (1), pp.106-122. ⟨10.1186/s12964-019-0413-8⟩ Article dans une revue inserm-02280785v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		Single-domain antibody-based and linker-free bispecific antibodies targeting FcγRIII induce potent antitumor activity without recruiting regulatory T cells. Caroline Rozan , Amélie Cornillon , Corinne Petiard , M. Chartier , G. Behar , et al. Molecular Cancer Therapeutics, 2013, 12 (8), pp.1481-1491. ⟨10.1158/1535-7163.MCT-12-1012⟩ Article dans une revue hal-02454959v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More
		[Bispecific antibodies: what future?] André Pèlegrin , Bruno Robert Médecine/Sciences, 2009, 25 (12), pp.1155-8. ⟨10.1051/medsci/200925121155⟩ Article dans une revue inserm-00446432v1	Envoyer sur ORCID Exporter BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite Export avancé Partager Gmail Facebook X LinkedIn More

Filtrer vos résultats

The HER3/ERBB3 receptor: the dark side of the ERBB planet

SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery

Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation

Symplekin promotes tumorigenicity by up-regulating claudin-2 expression

Examination of HER3 targeting in cancer using monoclonal antibodies

Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity

Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6 th antibody industrial symposium, June 25-26, 2018, Montpellier, France

Apoptosis and p53 are not involved in the anti-tumor efficacy of (125)I-labeled monoclonal antibodies targeting the cell membrane.

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis

Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent

Anti-HER2 vaccines: new prospects for breast cancer therapy.

[Anti-HER2 vaccines: The HER2 immunotargeting future?]

Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial

Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models

Time-resolved fluorescence resonance energy transfer (TR-FRET) to analyze the disruption of EGFR/HER2 dimers: a new method to evaluate the efficiency of targeted therapy using monoclonal antibodies.

The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts.

Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein.

In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption.

Adjuvant Radioimmunotherapy Trial with Iodine-131-Labeled Anti-Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab')2 after Resection of Liver Metastases from Colorectal Cancer.

A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions

Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation.

Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells

Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.

ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells

Single-domain antibody-based and linker-free bispecific antibodies targeting FcγRIII induce potent antitumor activity without recruiting regulatory T cells.

[Bispecific antibodies: what future?]